Harry Ahdieh

Efficacy and Safety of OPANA ER (Oxymorphone Extended Release) for Relief of Moderate to Severe Chronic Low Back Pain in Opioid-Experienced Patients: A 12-Week, Randomized, Double-blind, Placebo-controlled Study

M. Hale, Harry Ahdieh, Tina Ma et al. · Journal of Pain · 2006 · 168 citations

Pain Therapy, Pain Research, Health Sciences +12

A 12-week, randomized, placebo-controlled trial assessing the safety and efficacy of oxymorphone extended release for opioid-naive patients with chronic low back pain

Nathaniel P. Katz, Richard Rauck, Harry Ahdieh et al. · Current Medical Research and Opinion · 2006 · 136 citations

Oxymorphone Extended-Release Tablets Relieve Moderate to Severe Pain and Improve Physical Function in Osteoarthritis: Results of a Randomized, Double-Blind, Placebo- and Active-Controlled Phase III Trial

Alan K. Matsumoto, Najib Babul, Harry Ahdieh · Pain Medicine · 2005 · 118 citations · Full text

A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee

Alan Kivitz, Carl Ma, Harry Ahdieh et al. · Clinical Therapeutics · 2006 · 82 citations

Pain Medicine, Phase Iii Trial, Chronic Musculoskeletal Condition +6

Establishing the dosage equivalency of oxymorphone extended release and oxycodone controlled release in patients with cancer pain: a randomized controlled study

Nashat Gabrail, Chris Dvergsten, Harry Ahdieh · Current Medical Research and Opinion · 2004 · 79 citations